Reply to "Letter to the Editor Regarding 'COVID-19 outcomes in patients with Dermatomyositis: A registry-based cohort analysis'".

Pakhchanian, H; Raiker, R; Agarwal, Vikas; Gupta, Latika

Pakhchanian, H; Raiker, R; Agarwal, Vikas; Gupta, Latika.

Pakhchanian H; George Washington School of Medicine & Health Sciences, Washington DC, USA.
Raiker R; West Virginia University School of Medicine, Morgantown, West Virginia, USA.
Agarwal V; Department of Clinical Immunology Sanjay Gandhi Postgraduate Institute of Medical Sciences Lucknow, India, 226014.
Gupta L; Department of Rheumatology, Royal Wolverhampton Hospitals NHS Trust, Wolverhampton, UK; Department of Rheumatology, City Hospital, Sandwell and West Birmingham Hospitals NHS Trust, Birmingham, UK; Division of Musculoskeletal and Dermatological Sciences, Centre for Musculoskeletal Research, School of

Semin Arthritis Rheum ; 60: 152180, 2023 06.

Artículo en Inglés | MEDLINE | ID: covidwho-2325397

Asunto(s)

COVID-19; Dermatomiositis; Humanos; Dermatomiositis/complicaciones; Sistema de Registros; Estudios de Cohortes

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: Disponible Colección: Bases de datos internacionales Base de datos: MEDLINE Asunto principal: Dermatomiositis / COVID-19 Tipo de estudio: Estudio de cohorte / Estudio observacional / Estudio pronóstico Tópicos: Covid persistente Límite: Humanos Idioma: Inglés Revista: Semin Arthritis Rheum Año: 2023 Tipo del documento: Artículo País de afiliación: J.semarthrit.2023.152180

Similares

MEDLINE

LILACS

LIS

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google